Internal Medicine · Jersey City, NJ
NPI
1487723243
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
559 W Side Ave
Jersey City, NJ, 07304
Phone (201) 432-5300
Medicare paid, 2024
$40K
546 services
Medicare patients, 2024
91
Average age 69
Drug cost, 2024
$1.2M
12,004 prescriptions
Company payments, 2025
$597
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Solomon Owusu was code 99214 (office e&m - established), 206 times for 76 patients. In total Solomon Owusu billed 546 services in 13 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 206 | 76 | $89.13 | $18K |
| 99213 Office E&M - Established | Office | 191 | 58 | $69.48 | $13K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 23 | 23 | $129.24 | $2,973 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 23 | 23 | $21.08 | $485 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 21 | 21 | $21.08 | $443 |
By year: 2022 $18K for 251 services; 2023 $35K for 459 services; 2024 $40K for 546 services.
Medicare prescription drug claims, 2024
In 2024, the drug Solomon Owusu prescribed most often to Medicare patients was Amlodipine Besylate, with 1,100 prescriptions and refills. In total Solomon Owusu wrote 12,004 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,100 | 2,066 | 244 | $5,293 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 780 | 1,391 | 157 | $7,470 |
| Pantoprazole Sodium Generic | 532 | 850 | 145 | $3,684 |
| Metformin Hcl Generic | 439 | 794 | 93 | $2,497 |
| Rosuvastatin Calcium Generic | 423 | 872 | 105 | $6,329 |
| Levocetirizine Dihydrochloride Generic | 421 | 650 | 123 | $2,579 |
| Hydralazine Hcl Generic | 380 | 744 | 83 | $3,050 |
| Atorvastatin Calcium Generic | 373 | 635 | 83 | $2,711 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 330 | 356 | 63 | $7,920 |
| Pravastatin Sodium Generic | 316 | 589 | 66 | $2,728 |
| Carvedilol Generic | 231 | 404 | 45 | $1,380 |
| Gabapentin Generic | 217 | 375 | 57 | $2,641 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 202 | 202 | 121 | $2,082 |
| Clopidogrel Clopidogrel Bisulfate | 199 | 419 | 50 | $1,765 |
| Olmesartan-Hydrochlorothiazide Olmesartan/Hydrochlorothiazide | 168 | 362 | 44 | $4,179 |
Brand drugs: 1,731 claims; generic drugs: 10,028 claims; opioid claims: 71.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Solomon Owusu $597 ($597 in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $211.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $211 |
| Novo Nordisk Inc NVO | 10 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $82.93 |
| Lilly USA, LLC LLY | 2 | $43.71 |
| Dexcom, Inc. DXCM | 2 | $38.43 |
| Xeris Pharmaceuticals, Inc. | 1 | $27.97 |
| Verona Pharma, Inc. VRNA | 1 | $18.27 |
| GlaxoSmithKline, LLC. GSK | 1 | $16.87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.